Skip to content
Screener

Net margin at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
18.9%+8.4pp
Gilead Sciences logo
Gilead SciencesGILD
-10.6%-32.5pp
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-606.2%-212pp
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-284.2%+937pp
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
-672.2%-139pp
Allogene Therapeutics logo
Allogene TherapeuticsALLO
-1,170,863.6%-2,007,890pp

Other financials

Income statement

See full
Revenue-
Operating income-$26.9M-17.9%
Net income-$25.0M-17.6%
EPS (diluted)-$0.63+27.6%

Balance sheet

See full
Cash & equivalents$301.9M+944%
Total debt$9.8M-25.5%
Total equity$347.5M+133%
Total assets$368.6M+118%

Cash flow

See full
Operating cash flow-$20.4M+11.4%
CapEx$415.0K-60.7%
Free cash flow-$20.8M+13.6%

Valuation

See full
Market cap$550.99M+783%
Enterprise value$258.93M+455%

Profitability

See full
Operating margin-83.9%

Returns & leverage

See full
Return on equity-36.6%
Debt / equity-0.1×
Current ratio24.2×+10.3×

Where this comes from

Calculated from Artiva Biotherapeutics, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2025. Open the filing →

Filed
May 8, 2025
Fiscal quarter
Q1 FY2025
Calendar quarter
Q1 2025
Accession
0000950170-25-066421

FAQ

What is Artiva Biotherapeutics, Inc.'s net margin?
Artiva Biotherapeutics, Inc. (ARTV) reported net margin of -79.3% in Q1 2024.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Ask your AI about Artiva Biotherapeutics, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude